Malignant neoplasm of the axillary tail of an unspecified female breast is a type of breast cancer that originates in the axillary tail region, which is an extension of breast tissue. This condition is clinically significant due to its potential for metastasis and impact on treatment decisions. The ICD-10 Code C50.619 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage cases of breast cancer.
ICD-10 Code C50.619 represents a malignant neoplasm located in the axillary tail of an unspecified female breast. This code is used when a diagnosis of breast cancer is confirmed in this specific area, which may not have been previously documented. It is essential for clinical documentation and billing purposes, particularly when coding for cancer treatment and management.
Malignant neoplasm of the axillary tail of the breast is characterized by uncontrolled cell growth in the breast tissue extending into the axillary region. This condition can arise from various risk factors, including genetic predisposition and environmental influences. Early detection and treatment are crucial to improve patient outcomes.
ICD-10 Code C50.619 is utilized in SOAP notes to document the diagnosis of malignant neoplasm in the axillary tail of the breast. It plays a critical role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code C50.619 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of breast cancer. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of malignant neoplasm of the axillary tail of the breast typically requires a multidisciplinary approach, including surgical intervention, chemotherapy, and radiation therapy.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C50.619 is crucial for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for cancer care.
CPT Code | Description |
---|---|
19301 | Mastectomy, total or partial, for malignant neoplasm. |
96413 | Chemotherapy administration, intravenous, push technique. |
77067 | Breast MRI for evaluation of neoplasm. |
99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C50.619 for Malignant neoplasm of axillary tail of unsp female breast
What are the common symptoms of malignant neoplasm in the axillary tail?
Common symptoms include a palpable mass in the axillary region, changes in breast shape, and possible pain or discomfort. Patients may also experience skin changes such as dimpling or erythema.
How is the diagnosis of C50.619 confirmed?
Diagnosis is typically confirmed through imaging studies such as mammograms or ultrasounds, followed by a biopsy to obtain tissue samples for histopathological examination.
What treatment options are available for this condition?
Treatment options may include surgical resection, chemotherapy, radiation therapy, and hormonal therapy, depending on the stage and characteristics of the tumor.
How does this code impact billing and insurance claims?
ICD-10 Code C50.619 is essential for accurate billing, as it provides a specific diagnosis that supports the medical necessity of treatments and procedures performed for breast cancer management.
Clinical Notes
SOAP notes
DAP notes
AI medical notes